BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026
read at BioSpace ↗Neutral
BioSpace introduced a new IPO dashboard that monitors U.S. biotech companies that went public in 2026.
The tool will be refreshed weekly with the latest closing prices and will add any newly listed firms, giving investors and analysts a single source for post-IPO performance data.
The launch comes as biotech IPO activity rebounds after a period of slowdown, providing the industry with timely market insights.
source
This writeup was produced by pharmadog from original reporting by BioSpace.
Original headline: “2026 IPO stock tracker: How newly public biotechs are performing”
read at BioSpace ↗157 words · retrieved Jul 20
comments(0)
5-min edit window · permanent after that